Cencora, Inc. (COR)
Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Cencora (COR) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Retain Cencora Stock in Your Portfolio Now
Cencora's strength in U.S. Healthcare Solutions, along with rising specialty drug demand and biosimilar adoption, supports growth, though competitive pressures and international weakness remain headwinds.
Here's Why Cencora (COR) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like NVDA, RL, EXPE and COR are seeing price strength and have a high chance of carrying the momentum forward.
Cencora to Acquire OneOncology to Expand Community Oncology Solutions
COR's $3.6 billion move to take control of OneOncology boosts its pharma-centric strategy and lifts its long-term growth outlook despite a short-term dip.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.
Why Is Cencora (COR) Down 6.3% Since Last Earnings Report?
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cencora (COR) Upgraded to Buy: Here's Why
Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
